High Doses of Colchicine Act As "Silver Bullets" Against Severe COVID-19

被引：7

作者：

Lilov, Alexander ^{[1
]}

Palaveev, Kiril ^{[1
]}

Mitev, Vanyo ^{[2
]}

机构：

[1] Sofia Dist Hosp, Specialized Hosp Act Treatment Pneumopneumonia Pht, Pulmonol, Sofia, Bulgaria

[2] Med Univ Sofia, Chem & Biochem, Sofia, Bulgaria

来源：

CUREUS JOURNAL OF MEDICAL SCIENCE | 2024年 / 16卷 / 02期

关键词：

obesity; survival; colchicine; nlrp3; inflammasome; covid-19;

D O I：

10.7759/cureus.54441

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A 48-year-old patient with a weight of 120 kg with type 2 diabetes mellitus, hypertension, and gout was hospitalized on the third day of the COVID-19 diagnosis. His general condition is relatively good, oxygen saturation is 89%. Despite starting standard treatment, on the seventh day from the onset of symptoms, the patient deteriorated sharply (oxygen saturation dropped to 74%). The negative development of the disease is interrupted with a loading dose of colchicine of 6 mg. This is a typical case of the life-saving effect of high but safe doses of colchicine in high-risk COVID-19 patients.

引用

页数：8

共 50 条

[31] Effect of colchicine on clinical outcomes in COVID-19
Abdenneji, S.
Fekih, W.
Ben Krayen, I.
El Ghoul, J.
EUROPEAN RESPIRATORY JOURNAL, 2022, 60
[32] COVID-19 cardiac injury and the use of colchicine
Anton-Vazquez, Vanesa
Byrne, Laura
Anderson, Lisa
Hamzah, Lisa
BMJ CASE REPORTS, 2021, 14 (02)
[33] Colchicine in the management of Covid-19: With or lieu of evidence
Al-Kuraishy, Hayder Mutter
Hussien, Nawar Raad
Al-Niemi, Marwa Salih
Al-Gareeb, Ali Ismail
JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2021, 71 (12) : S127 - S132
[34] Use of colchicine in COVID-19 hospitalized patients
Korra, Emad E. A.
AbdelFattah, Eman B.
Ahmed, Mervat A.
EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2022, 71 (03): : 290 - 295
[35] Colchicine as a Potential Therapeutic Agent Against Cardiovascular Complications of COVID-19: an Exploratory Review
Christodoulos Papadopoulos
Dimitrios Patoulias
Eleftherios Teperikidis
Dimitrios Mouselimis
Anastasios Tsarouchas
Maria Toumpourleka
Aristi Boulmpou
Constantinos Bakogiannis
Michael Doumas
Vassilios P. Vassilikos
SN Comprehensive Clinical Medicine, 2020, 2 (9) : 1419 - 1429
[36] Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes (vol 14, 1273, 2023)
Grewal, Ramandip
Nguyen, Lena
Buchan, Sarah A.
Wilson, Sarah E.
Nasreen, Sharifa
Austin, Peter C.
Brown, Kevin A.
Fell, Deshayne B.
Gubbay, Jonathan B.
Schwartz, Kevin L.
Tadrous, Mina
Wilson, Kumanan
Kwong, Jeffrey C.
NATURE COMMUNICATIONS, 2024, 15 (01)
[37] Paradox of COVID-19 in pregnancy: are pregnant women more protected against or at elevated risk of severe COVID-19?
Santa, Sheila
Doku, Derek A.
Olwal, Charles O.
Brown, Charles A.
Tagoe, Emmanuel A.
Quaye, Osbourne
FUTURE MICROBIOLOGY, 2022, 17 (10) : 803 - 812
[38] COVID-19: Is there a silver lining?
Kalra, Kriti
Deshmukh, Paulami
JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2020, 70 (05) : S175 - S176
[39] Booster Doses of COVID-19 Vaccines
不详
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2021, 63 (1638): : 186 - 188
[40] India Reaches Landmark 1 Billion of Vaccine Doses Against COVID-19
Gupta, S. D.
Mangal, D. K.
JOURNAL OF HEALTH MANAGEMENT, 2021, 23 (04) : I - II

← 1 2 3 4 5 →